Dr. Vince Clinical Research Expands Leadership in Renal and Hepatic Clinical Pharmacology Studies

Dr. Vince Clinical Research (DVCR), a leading contract research organization (CRO), today announced the appointment of Harry Alcorn, PharmD, as Senior Vice President of Renal and Hepatic Research. In ...
The Manila Times

Quoin Pharmaceuticals Provides Clinical and Regulatory Update from Constructive Type C Meeting with U.S. FDA for QRX003 in Netherton Syndrome

FDA indicated that a single Phase 3 study may be sufficient to support marketing approval in the U.S. FDA expressed openness ...

Enhancing clinical trials with real-world data

Sujay Jadhav, CEO of Verana Health highlights how real-time real-world data dashboards are transforming the way life sciences ...

Lauded Study Finds Surgery May Not Be Necessary for Precancerous Breast Condition

Thomas Jefferson University biostatistician Terry Hyslop designed a trial showing active monitoring to be as effective as ...

NetraMark Announces Strategic Oncology Research Collaboration with Fondazione per la Medicina Personalizzata to Analyze Landmark ROME Trial Dataset

The collaboration aims to uncover clinically actionable patient subpopulations and biomarker-driven treatment insights from a landmark precision-oncology trialTORONTO, March 25, 2026 (GLOBE NEWSWIRE) ...
The Manila Times

Innovent Announces First Participant Dosed of IBI128 (Tigulixostat, XOI) in Phase 3 Clinical Study

Innovent Biologics, Inc. ('Innovent', HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and ...

Theriva™ Biologics Announces Positive End-of-Phase 2 Meeting with U.S. FDA Regarding the Design of a Phase 3 Trial of VCN-01 in Metastatic Pancreatic Ductal Adenocarcinoma

Successful meeting with FDA enables advancement into proposed Phase 3 clinical trial of VCN-01 in combination with gemcitabine/nab-paclitaxel for the first-line treatment of metastatic PDAC – – ...

Innovent Biologics: Innovent Announces First Participant Dosed of IBI128 (Tigulixostat, XOI) in Phase 3 Clinical Study

SAN FRANCISCO and SUZHOU, China, March 22, 2026 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent", HKEX: 01801), a world-class biopharmaceutical company that develops ...

NetraMark Holdings Inc.: NetraMark Announces Strategic Oncology Research Collaboration with Fondazione per la Medicina Personalizzata to Analyze Landmark ROME Trial Dataset

NetraMark Holdings Inc. (the "Company" or "NetraMark") (TSX: AIAI) (OTCQB: AINMF) (Frankfurt: PF0), a premier artificial intelligence (AI) company transforming ...
Multiple Sclerosis News Today

Age plays role in how RRMS affects brain volume over time

A study found brain atrophy progresses more slowly with age in RRMS, highlighting the need to factor age into MS clinical ...
Becker's Hospital Review

AI workflow design may reduce perceived malpractice risk: Study

AI workflow design may reduce malpractice risk by influencing juror decisions in radiology cases, finds study from Penn State ...